VTR
50
-5
CVX
47
9
KSS
46
4
MAR
69
-3
CME
58
-4
SE
57
-3
WDC
41
3
DE
39
3
PM
64
6
AZO
55
-3
DIS
68
6
LB
30
-22
AIG
44
-3
M
36
5
HST
43
-7
NWL
50
-6
R
75
-2
CTSH
63
-2
MSI
76
-3
STX
50
-2
VTR
50
-5
CVX
47
9
KSS
46
4
MAR
69
-3
CME
58
-4
SE
57
-3
WDC
41
3
DE
39
3
PM
64
6
AZO
55
-3
DIS
68
6
LB
30
-22
AIG
44
-3
M
36
5
HST
43
-7
NWL
50
-6
R
75
-2
CTSH
63
-2
MSI
76
-3
STX
50
-2
Financhill
Back

EyePoint Pharmaceuticals Quote, Financials, Valuation and Earnings

Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term

See if stocks could soar as much as 1,000% if history repeats itself.
Buy
69

EYPT
EyePoint Pharmaceuticals

Last Price:
9.47
Seasonality Move:
27.28%

7 Day Trial

ALL ACCESS PASS

$ 7

"This Changes Everything" - Trump Hands Millions Massive IRS Gift

Learn More Here

EyePoint Pharmaceuticals Price Quote

$9.47
-1.02 (-9.72%)
(Updated: November 15, 2024 at 3:10 PM ET)

EyePoint Pharmaceuticals Key Stats

Buy
69
EyePoint Pharmaceuticals (EYPT) is a Buy
Day range:
$10.26 - $10.83
52-week range:
$5.86 - $30.99
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.63
P/B ratio:
3.27%
Volume:
795K
Avg. volume:
921.8K
1-year change:
62.13%
Market cap:
$716M
Revenue:
$46M
EPS:
$-1.99

How Much Does EyePoint Pharmaceuticals Make?

Is EyePoint Pharmaceuticals Growing As A Company?

EyePoint Pharmaceuticals Stock Price Performance

What Is EyePoint Pharmaceuticals 52-Week High & Low?

EyePoint Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy EyePoint Pharmaceuticals?

Is EyePoint Pharmaceuticals Cash Flow Positive?

  • What Is EYPT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$113.5M
  • What Is EyePoint Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $230.8M
  • What Is EyePoint Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$170.5M

EyePoint Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    EYPT return on invested capital is -50.67%
  • What Is EyePoint Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is -35.24%
  • What Is EYPT Return On Equity?
    ROE is a measure of profitability and is -50.67%

EyePoint Pharmaceuticals Earnings Date & Stock Price

EyePoint Pharmaceuticals Competitors

EyePoint Pharmaceuticals Dividend Yield

EyePoint Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -0.17%
Revenue: -30.77% 1.6%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 33.45
Upside from Last Price: 218.92%

Major Shareholders

  • How many EYPT shares are owned by institutional investors?
    99.4M EYPT shares are owned by institutional investors
  • How many EYPT shares are owned by insiders?
    1.4M EYPT shares are owned by insiders